BioCentury
ARTICLE | Company News

Vernalis, Servier deal

October 11, 2010 7:00 AM UTC

Vernalis will receive a €750,000 ($1 million) milestone payment from Servier under a 2009 cancer drug discovery deal. The payment was triggered by achievement of desired potency and selectivity criter...